4.5 Review

In vivo praziquantel efficacy of Schistosoma japonicum over time: A systematic review and meta-analysis

期刊

ACTA TROPICA
卷 222, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.actatropica.2021.106048

关键词

Praziquantel; Schistosoma japonicum; Drug efficacy; Resistance; Laboratory mouse; Systematic review; Meta-analysis

资金

  1. National Science Foundation of China [81971957]
  2. Jiangsu Provincial Project of Invigorating Health Care through Science, Technology and Education [wk018-001]
  3. ZELS research grant (BBSRC)
  4. ZELS research grant (MRC)
  5. ZELS research grant (ESRC)
  6. ZELS research grant (NERC)
  7. ZELS research grant (DSTL)
  8. ZELS research grant [DFID: BB/S013822/1]

向作者/读者索取更多资源

A study on the efficacy of PZQ against S. japonicum in China found an increase in D over time, while R slightly decreased, both significantly correlated with the total drug dose, indicating no evidence of PZQ-R emergence. Further research is needed to explore the potential factors affecting these findings.
Praziquantel (PZQ), the only choice of chemotherapy for schistosomiasis recommended by World Health Organization (WHO), has been widely used over 40 years. The long-term, and rapid expansion of, PZQ use for disease control across a large populations continues to raise concern regarding the potential for emergence and establishment of drug resistance. Recent research has also proposed that the long survival and low sensitivity of unpaired worms, derived from either incomplete treatment cure rates or single-sex schistosome infections within final hosts, could exacerbate the risk of PZQ resistance (PZQ-R) emerging. With the aim of assessing whether PZQ efficacy amongst S. japonicum may have changed over time in China, we performed a unique systematic review and meta-analyses on datasets which evaluated the efficacy of PZQ via laboratory assays of field S. japonicum isolates on experimental mice over time. Relevant published literatures from four electronic bibliographic databases and lists of article references were searched. Two indexes, d, a measure used in meta-analyses for worm burden difference between two groups, and r, a traditional measure for worm reduction percentage after treatment but without considering sample size were calculated for each study. A total of 25 papers including 127 experimental studies with eligible data on 2230 mice were retrieved. The pooled d (D) was 3.91 (3.56-4.25) and pooled r (R) was 54.52% (52.55%-56.52%). D significantly increased over time, whereas R non-significantly decreased; both estimates were significantly associated with the total drug dose. Such findings suggested no evidence of PZQ-R emergence S. japonicum to date. However, we consider the potential role of parasite origins, PZQ dosage, and single versus mixed gender infections of the results published to date, and the avenues now needed for further research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据